Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00914836
Other study ID # 19-09
Secondary ID
Status Withdrawn
Phase N/A
First received May 17, 2009
Last updated June 21, 2015
Start date June 2009
Est. completion date April 2010

Study information

Verified date June 2015
Source HaEmek Medical Center, Israel
Contact n/a
Is FDA regulated No
Health authority Israel: Ministry of Health
Study type Interventional

Clinical Trial Summary

The use of corticosteroid subacromial injections have been found to be effective for the treatment of shoulder pain. Higher doses may be better than lower doses for subacromial corticosteroid injection for rotator cuff tendonitis. The investigators aim this study to compare 2 doses of corticosteroids.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date April 2010
Est. primary completion date April 2010
Accepts healthy volunteers No
Gender Both
Age group 35 Years and older
Eligibility Inclusion Criteria:

- subacromial bursitis

- tendinitis

- Calcific Tendonitis

Exclusion Criteria:

- rotator cuff tear

- osteoarthritis

- pregnancy

- local or systemic infection

- steroid or lidocaine sensitivity

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Betamethasone Sodium Phosphate
1cc:2cc
1 cc - Betamethasone Sodium Phosphate
Betamethasone Sodium Phosphate
2 cc - Betamethasone Sodium Phosphate
Betamethasone Sodium Phosphate

Locations

Country Name City State
Israel Haemek Medical Center Afula

Sponsors (1)

Lead Sponsor Collaborator
HaEmek Medical Center, Israel

Country where clinical trial is conducted

Israel, 

References & Publications (1)

van der Heijden GJ, van der Windt DA, Kleijnen J, Koes BW, Bouter LM. Steroid injections for shoulder disorders: a systematic review of randomized clinical trials. Br J Gen Pract. 1996 May;46(406):309-16. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary constant score 9 month No
See also
  Status Clinical Trial Phase
Completed NCT01205477 - Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment Phase 2
Terminated NCT01807962 - Local Injection Under US Control in GTPS. Phase 3
Completed NCT01050465 - MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use N/A
Completed NCT02841462 - Hydrothermal Ablation in Recurrent and Chronic Symptomatic Bursitis N/A
Withdrawn NCT00863889 - Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome Phase 4
Completed NCT00480675 - Randomized Study Comparing Fluoroscopically-Guided Versus Blinded Trochanteric Bursa Injections N/A
Completed NCT00352625 - Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis Phase 3
Terminated NCT04931511 - Comparison Between Subacromial Ultrasound Guided and Systemic Steroid Injection for Frozen Shoulder Phase 4
Completed NCT01161615 - MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder Phase 3
Terminated NCT00426985 - Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Shoulder, Elbow or Knee Tendonitis or Bursitis Phase 3
Completed NCT00634608 - Integrating Targeted MedlinePlus Health Prescriptions Into Clinic Practice Workflow N/A
Completed NCT01506154 - Safety & Efficacy Study of MRX-7EAT Patch in the Treatment of Pain of the Shoulder Phase 3
Completed NCT02221817 - Comparison of Ultrasound Guided Versus Blind Corticosteroid Injection for Trochanteric Bursitis N/A
Completed NCT02126878 - Comparison of Steroid Dosages on the Efficacy of Trochanteric Bursa Injection N/A